CJS Securities Starts TherapeuticsMD (TXMD) at Market Outperform
Tweet
Share
E-mail
Get Alerts TXMD Hot Sheet
Price: $2.07 -0.48%
Rating Summary:
10 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
10 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
CJS Securities analyst Larry Solow initiates coverage on TherapeuticsMD (NASDAQ: TXMD) with a Market Outperform rating and a price target of $6.00.
For an analyst ratings summary and ratings history on TherapeuticsMD click here. For more ratings news on TherapeuticsMD click here.
Shares of TherapeuticsMD closed at $2.42 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Starts SpyGlass Pharma (SGP) at Outperform
- BofA Securities Resumes American Eagle Outfitters (AEO) at Underperform
- Evercore ISI Starts Alvotech SA (ALVO) at Outperform
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
